Status:
COMPLETED
Evaluation of Atomoxetine for Cocaine Dependence: A Pilot Trial
Lead Sponsor:
Sharon Walsh
Collaborating Sponsors:
Eli Lilly and Company
National Institute on Drug Abuse (NIDA)
Conditions:
Substance Abuse
Eligibility:
All Genders
18-60 years
Phase:
PHASE2
Brief Summary
This placebo-controlled, double-blind, randomized pilot clinical trial will evaluate atomoxetine (Strattera®) for the treatment of cocaine dependence. Cocaine-dependent individuals, who are healthy an...
Eligibility Criteria
Inclusion
- Seeking treatment for cocaine dependence
- Must have used cocaine in the past 30 days
Exclusion
- Physical dependence on any drug requiring medical management
- Any major medical or psychiatric disorder that would be contraindicated for participation
- Cardiovascular disease
- Seizures or significant head injuries
- Currently taking atomoxetine
- Pregnant or breast-feeding
Key Trial Info
Start Date :
July 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00617201
Start Date
July 1 2007
End Date
August 1 2011
Last Update
August 31 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Straus Research Building
Lexington, Kentucky, United States, 40502